Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer
- PMID: 27583806
- DOI: 10.1002/cncr.30320
Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer
Abstract
Background: Many men with prostate cancer (PC) require long-term androgen deprivation therapy (ADT), but to the authors' knowledge, its effects on cognitive function beyond 1 year are not described.
Methods: Three groups of men aged ≥50 years who were matched based on age and education were enrolled: 77 patients with nonmetastatic PC who initiated continuous ADT, 82 patients with PC who were not receiving ADT (PC controls), and 82 healthy controls. A battery of 14 neuropsychological tests, examining 8 cognitive domains, was administered on 5 occasions over 36 months. Changes in cognitive scores over time were analyzed using 3 approaches: linear mixed effects regression, the percentage of participants per group with declines in ≥1/2 cognitive tests, and a global summary of cognitive change.
Results: The mean age of the study subjects was 68.9 years, with a median of 16 years of education. In mixed effects models adjusted for age and education, ADT use was not found to be associated with significant changes over time in any cognitive test compared with healthy controls. The percentage of participants declining by ≥1.5 standard deviations in ≥2 tests or ≥2 standard deviations in ≥1 tests was similar across groups. A global summary of cognitive change found no statistically significant worsening of cognitive function among ADT users compared with controls. Sensitivity analyses adjusting for duration of ADT and using multiple imputation for missing data did not materially alter the study findings.
Conclusions: The ongoing use of ADT for up to 36 months does not appear to be associated with cognitive decline. Cancer 2017;123:237-244. © 2016 American Cancer Society.
Keywords: adverse effects; androgen deprivation therapy; cognitive function; cohort study; neuropsychological testing; prostate cancer.
© 2016 American Cancer Society.
Comment in
-
The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction.Eur Urol Focus. 2023 May;9(3):409-410. doi: 10.1016/j.euf.2023.03.015. Epub 2023 Mar 31. Eur Urol Focus. 2023. PMID: 37005166
Similar articles
-
The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.Psychooncology. 2020 Aug;29(8):1338-1346. doi: 10.1002/pon.5442. Epub 2020 Jul 2. Psychooncology. 2020. PMID: 32539186
-
Dissociation of event-based prospective memory and time-based prospective memory in patients with prostate cancer receiving androgen-deprivation therapy: a neuropsychological study.Eur J Cancer Care (Engl). 2015 Mar;24(2):198-204. doi: 10.1111/ecc.12299. Eur J Cancer Care (Engl). 2015. PMID: 25711542
-
Impact of Androgen Deprivation Therapy on Self-Reported Cognitive Function in Men with Prostate Cancer.J Urol. 2018 Aug;200(2):327-334. doi: 10.1016/j.juro.2018.02.073. Epub 2018 Mar 1. J Urol. 2018. PMID: 29477720
-
Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.Support Care Cancer. 2014 Aug;22(8):2271-80. doi: 10.1007/s00520-014-2285-1. Epub 2014 May 25. Support Care Cancer. 2014. PMID: 24859915 Free PMC article. Review.
-
Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer.Curr Oncol Rep. 2020 Feb 11;22(3):24. doi: 10.1007/s11912-020-0884-1. Curr Oncol Rep. 2020. PMID: 32048059 Review.
Cited by
-
Impact of androgen deprivation therapy on cognitive function in men with prostate cancer.BJUI Compass. 2023 Dec 11;5(3):356-358. doi: 10.1002/bco2.319. eCollection 2024 Mar. BJUI Compass. 2023. PMID: 38481674 Free PMC article. No abstract available.
-
A review of the objective cognitive function measurements in males receiving hormonal therapy for prostate cancer.Investig Clin Urol. 2023 Nov;64(6):521-540. doi: 10.4111/icu.20230103. Investig Clin Urol. 2023. PMID: 37932563 Free PMC article. Review.
-
A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors.Cancers (Basel). 2023 Feb 14;15(4):1215. doi: 10.3390/cancers15041215. Cancers (Basel). 2023. PMID: 36831557 Free PMC article. Review.
-
Effects of androgen deprivation on white matter integrity and processing speed in prostate cancer patients.Am J Cancer Res. 2022 Oct 15;12(10):4802-4814. eCollection 2022. Am J Cancer Res. 2022. PMID: 36381311 Free PMC article.
-
[Testosterone and Alzheimer's disease].Probl Endokrinol (Mosk). 2022 Jun 24;68(5):97-107. doi: 10.14341/probl13136. Probl Endokrinol (Mosk). 2022. PMID: 36337024 Free PMC article. Russian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical